Primary Article

Use of Bovine Heterografts in Intravenous Therapy

Authors: HOWARD G. DAWKINS JR ., MD, PAUL M. JAMES JR ., MD

Abstract

ABSTRACT:Thirteen bovine heterografts were placed in nine patients: three for renal dialysis, four for treatment of diabetes mellitus, and six for cancer chemotherapy. One graft became occluded on the night of operation. One graft caused dilation of distal veins sufficient for dialysis and was never used; this graft was occluded by a blow ten months later. Two grafts were thrombosed by poor puncture technic, one after three months' use and one after seven months' use. One graft became infected, then thrombosed, and was never used. The remaining eight have served as intravenous conduits for 6 to 19 months. Despite the problems we have encountered with these grafts, we believe that their use is the procedure of choice in cancer patients with limited life spans, even when such patients have available and satisfactory saphenous veins. The establishment of a bovine heterograft requires less time than establishment of a saphenous vein graft and requires only regional or local anesthesia—both advantages in seriously ill patients.

This content is limited to qualifying members.

Existing members, please login first

If you have an existing account please login now to access this article or view purchase options.

Purchase only this article ($25)

Create a free account, then purchase this article to download or access it online for 24 hours.

Purchase an SMJ online subscription ($75)

Create a free account, then purchase a subscription to get complete access to all articles for a full year.

Purchase a membership plan (fees vary)

Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.

References